Replication of HIV-1 in vivo and in vitro

被引:27
|
作者
Orenstein, Jan Marc [1 ]
机构
[1] Washington Univ, Med Ctr, Dept Pathol, Washington, DC 20037 USA
关键词
HIV; in vitro; in vivo; macrophage; TEM;
D O I
10.1080/01913120701344343
中图分类号
TH742 [显微镜];
学科分类号
摘要
A complex relationship exists between HIV and its cellular targets. The lethal effect of HIV on circulating CD4(+) helper T lymphocytes parallels the degree of the infected individual's immunodeficiency and ultimately the transition to AIDS and death. However, as with other members of the Lentivirus family of retroviruses, the ubiquitous, mobile macrophage is also a prime target for HIV infection, and apparently, in most instances, is the initial infected cell, since most people are infected with a CCR5 chemokine-tropic virus. Unlike the lymphocyte, the macrophage is apparently a more stable viral host, capable of a long infected life as an HIV reservoir and a chronic source of infectious virus. Published in vitro studies have indicated that whereas lymphocytes replicate HIV solely on their plasma membrane, macrophages have been envisaged to predominantly replicate HIV within cytoplasmic vacuoles, and thus have been likened to a "Trojan horse,'' when it comes to the immune system. Recent studies have revealed an ingenious way by which the cultured monocyte-derived macrophage (MDM) replicates HIV and releases it into the medium. The key macrophage organelle appears to be what is alternatively referred to as the "late endosome'' ( LE) or the "multivesicular body'' (MVB), which have a short and a long history, respectively. Proof of the association is that chemically, LE/MVB and their vesicles possess several pathopneumonic membrane markers ( e.g., CD63) that are found on released HIV particles. The hypothesis is that HIV usurps this vesicle-forming mechanism and employs it for its own replication. Release of the intravacuolar virus from the cell is hypothesized to occur by a process referred to as exocytosis, resulting from the fusion of virus-laden LE=MVB with the plasma membrane of the macrophage. Interestingly, LE=MVB are also involved in the infection stage of MDM by HIV. Close review of the literature reveals that along with the Golgi, which contributes to the formation of LE=MVB, the MVB was first identified as a site of HIV replication by macrophages many years ago, but the full implication of this observation was not appreciated at the time. As in many other areas of HIV research, what has been totally lacking is an in vivo confirmation of the in vitro phenomenon. Herein, the ultrastructure of HIV interaction with cells in vitro and in vivo is explored. It is shown that while HIV is regularly found in LE=MVB in vitro, it is infrequently the case in vivo. Therefore, the results challenge the "Trojan horse'' concept.
引用
收藏
页码:151 / 167
页数:17
相关论文
共 50 条
  • [21] IN-VIVO AND IN-VITRO INFECTION OF THE ASTROCYTE BY HIV-1
    CONANT, K
    TORNATORE, C
    ATWOOD, W
    MEYERS, K
    TRAUB, R
    MAJOR, EO
    ADVANCES IN NEUROIMMUNOLOGY, 1994, 4 (03): : 287 - 289
  • [22] In vitro and in vivo tumor growth suppression by HIV-1 Vpr
    Mahalingam, S
    Macdonald, B
    Ugen, KE
    Ayyavoo, V
    Agadjanyan, MG
    Williams, WV
    Weiner, DB
    DNA AND CELL BIOLOGY, 1997, 16 (02) : 137 - 143
  • [23] Negatively charged human serum albumins as inhibitors of HIV-1 replication: Mechanism of action, in vitro activity against distinct HIV-1 isolates and in vivo efficacy in mice
    Swart, PJ
    Kuipers, ME
    Schutten, M
    Huisman, JG
    Schuitemaker, H
    Osterhaus, ADME
    Meijer, DKF
    23RD INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, 1996 PROCEEDINGS, 1996, : 673 - 674
  • [24] Clastogenic factors in plasma of HIV-1 infected patients activate HIV-1 replication in vitro: Inhibition by superoxide dismutase
    Edeas, MA
    Emerit, I
    Khalfoun, Y
    Lazizi, Y
    Cernjavski, L
    Levy, A
    Lindenbaum, A
    FREE RADICAL BIOLOGY AND MEDICINE, 1997, 23 (04) : 571 - 578
  • [25] Synergistic inhibition of HIV-1 reverse transcriptase and HIV-1 replication by combining trovirdine with AZT, ddl and ddC in vitro
    Zhang, H
    Vrang, L
    Rydergard, C
    Ahgren, C
    Oberg, B
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1996, 7 (05): : 221 - 229
  • [26] μ-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication
    Steele, AD
    Henderson, EE
    Rogers, TJ
    VIROLOGY, 2003, 309 (01) : 99 - 107
  • [27] In vitro and in vivo cleavage of HIV-1 RNA by new SOFA-HDV ribozymes and their potential to inhibit viral replication
    Laine, Sebastien
    Scarborough, Robert J.
    Levesque, Dominique
    Didierlaurent, Ludovic
    Soye, Kaitlin J.
    Mougel, Marylene
    Perreault, Jean-Pierre
    Gatignol, Anne
    RNA BIOLOGY, 2011, 8 (02) : 343 - 353
  • [28] In vivo analysis of highly conserved Nef activities in HIV-1 replication and pathogenesis
    Richard L Watkins
    Wei Zou
    Paul W Denton
    John F Krisko
    John L Foster
    J Victor Garcia
    Retrovirology, 10
  • [29] In vivo analysis of highly conserved Nef activities in HIV-1 replication and pathogenesis
    Watkins, Richard L.
    Zou, Wei
    Denton, Paul W.
    Krisko, John F.
    Foster, John L.
    Garcia, J. Victor
    RETROVIROLOGY, 2013, 10
  • [30] Irradiation-induced cellular stress activates virus replication and apoptosis of HIV-1 infected cells in vitro and in vivo
    Kashanchi, F.
    Iordanskiy, S.
    Van Duyne, R.
    Sampey, G.
    Fry, K.
    Romerio, F.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2014, 9 (01) : 27 - 27